V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Director – Knowledge Graph & Semantics

Engineering LeadershipConfirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • Deep hands-on experience designing and operating enterprise knowledge graphs, including schema design, ingestion, query, and traversal patterns.
  • Familiarity with multiple graph paradigms, including property graph, RDF/semantic web, and hybrid graph plus vector approaches, and their trade-offs.
  • Strong experience building and governing semantic layers, such as dbt Semantic Layer, Cube, AtScale, LookML, or comparable tools, for consistent analytics and AI consumers.
  • Strong experience with Snowflake and/or Databricks in enterprise environments, including integration of graph and semantic capabilities with these platforms.
  • A track record of integrating data across multiple business domains, including entity resolution, master data, and lineage at enterprise scale.
  • Working understanding of how knowledge graphs and semantic layers are consumed by AI agents and RAG systems, including graph-aware retrieval and traversal for agent reasoning.
  • A track record of operating graph and analytical systems in production with high availability, query performance, and continuous improvement.
  • Proven ability to lead technical teams, communicate with executive stakeholders, and translate business needs into graph and semantic models.
  • 10+ years of experience in data engineering, artificial intelligence/machine learning, or advanced analytics, with 3+ years specifically focused on knowledge graphs, semantic technologies, or enterprise data modeling at scale.

Responsibilities

  • Design, build, and operate Vertex's enterprise knowledge graph spanning clinical, research, regulatory, and commercial domains, including ingestion, storage, query, and lifecycle management of nodes, edges, and properties.
  • Build and govern the enterprise semantic layer that enables metrics, dimensions, business entities, and relationships in a single, consistent model used by AI agents.
  • Define Vertex's strategy for the graph and semantic platform, including technology selection for the graph database, AI semantic layer tooling, and query API, and the architecture that unifies them.
  • Partner with the ontology and data modeling function to translate domain ontologies into the graph, ensuring fidelity to source models and consistency across domains.
  • Build graph traversal and retrieval interfaces that AI agents and other consumers use to ground their reasoning, including pattern queries, semantic search over graph context, and graph-aware retrieval for RAG systems.
  • Partner with application and system owners across Vertex to onboard their systems into the enterprise knowledge graph and semantic layer.
  • Own SLAs, observability, query performance, cost, and continuous improvement for the graph and semantic layer in production.
  • Define the graph and semantic strategy, select the underlying technology stack, and lead the engineering team that builds and operates the capability.

Desired Qualifications

  • Experience in pharmaceutical, biotech, or life sciences data environments; familiarity with clinical, regulatory, and commercial data domains is a plus.
  • Working knowledge of GxP, 21 CFR Part 11, and validated-system constraints on data and AI deployments.
  • Familiarity with industry ontologies and standards such as SNOMED CT, MedDRA, LOINC, RxNorm, CDISC, and IDMP, and how they map into enterprise graph models.
  • Hands-on experience with Cypher, SPARQL, Gremlin, GQL, or comparable graph query languages.
  • Experience with text-to-Cypher, text-to-SPARQL, or other LLM-driven graph query generation, and graph-augmented retrieval for AI systems.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs